ACACIA PHARMA news, videos and press releases - Page 3
For more news please use our advanced search feature.
ACACIA PHARMA - More news...
ACACIA PHARMA - More news...
- Holding(s) in Company
- Holding(s) in Company
- Holding(s) in Company
- Admission to Trading on Euronext Brussels
- Publication of Prospectus
- Results of Placing
- Proposed Capital Raising by way of a Placing of New Ordinary Shares
- Interim Results for the Six Months ended 30 June 2020
- Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®
- Holding(s) in Company
- Holding(s) in Company
- Holding(s) in Company
- Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies
- Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV
- Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedatio
- TR-1: Standard form for notification of major holdings
- TR-1: Standard form for notification of major holdings
- TR-1: Standard form for notification of major holdings
- Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals
- Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
- Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
- Alessandro Della Chà appointed as Director of Acacia Pharma Group plc
- Results of Annual General Meeting
- Publication of Prospectus
- Forthcoming 2020 Annual General Meeting – Change of Venue and Proxy Forms
- Acacia Pharma Group plc: Notice of Annual General Meeting
- Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation
- Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
- Acacia Pharma Announces Changes to its Officers and Board of Directors
- Acacia Pharma Group plc: Results for the year ended 31 December 2019
